<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Changes in regional metabolic activities induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) can influence patient outcome </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim was to demonstrate in a rat model that (18)F-FDG with <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography (PET) imaging is a quantitative, reproducible approach for identifying <z:hpo ids='HP_0011009'>acute</z:hpo> and sub-<z:hpo ids='HP_0011009'>acute</z:hpo> metabolic variations in <z:mpath ids='MPATH_124'>infarct</z:mpath> regions </plain></SENT>
<SENT sid="2" pm="."><plain>We found that imaging with (18)F-FDG/PET enabled detection and quantification of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced metabolic deficits and provided a sensitive and reliable means of assessing cerebral ischemic lesions compared with conventional neurological scoring systems in rodents </plain></SENT>
</text></document>